Expression of complement system components during aging and amyloid deposition in APP transgenic mice

Documenti analoghi

• The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
  di: Wiessner, Christoph, et al.
  Pubblicazione: (2011)
• IFNγ promotes complement expression and attenuates amyloid plaque deposition in APP transgenic mice
  di: Chakrabarty, Paramita, et al.
  Pubblicazione: (2010)
• Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice
  di: Bondolfi, Luca, et al.
  Pubblicazione: (2002)
• Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice
  di: Stalder, Martina, et al.
  Pubblicazione: (1999)
• Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice
  di: Mahler, Jasmin, et al.
  Pubblicazione: (2015)